HTR2C (5-hydroxytryptamine receptor 2C) variants and mutations
HTR2C (also known as 5-hydroxytryptamine receptor 2C) is a human protein-coding gene encoding a 5-hydroxytryptamine receptor 2C protein. Its serotonin-dependent signaling in hypothalamic and limbic circuits suppresses appetite and modulates mood, reward, and neuroendocrine function. Altered signaling can affect body weight and psychiatric drug responses, and the receptor is a pharmacologic target of several neuropsychiatric agents. This analysis covers 745 HTR2C variants and mutations. Of these, 89% have computational variant effect predictions. Disease context includes autism, schizophrenia, and bipolar disorder. Example HTR2C variants include M1?, V2L, and V2M.
Variant analysis overview
- Gene: HTR2C
- Protein: 5-hydroxytryptamine receptor 2C
- UniProt accession: P28335
- Organism: Homo sapiens
- Variants analyzed: 745
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 560 unspecified-consequence records; 108 missense variants; 60 synonymous variants; 1 in-frame deletions; 6 stop-gained variants; 7 frameshift variants; 3 splice-region variants
- Prediction scores: 661 variants have prediction scores (89% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: autism, schizophrenia, bipolar disorder, major depressive disorder, psychotic disorder, bipolar I disorder, aggressive behavior, Agitation, depressive disorder, Dravet syndrome, insomnia, obesity disorder.
Protein structure and variant hotspots
- Protein features: 7 transmembrane segments; 2 binding sites; 2 post-translational modification sites.
- Structural context: 245 variants have structural context.
- PTM context: 2 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable HTR2C variants
Examples include M1?, V2L, V2M, V2A, V2V, N3K, N3S, N3H. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV5220, NCI-TCGA Cosmic COSV5222, cosmic curated COSV52225, Variant assessed as somatic; high impact.
- V2L (p.Val2Leu), TOPMed rs200113008, REVEL 0.13, MetaLR 0.08, Uncertain significance
- V2M (p.Val2Met), TOPMed rs200113008, REVEL 0.14, MetaLR 0.09, Uncertain significance, HTR2C-related disorder
- V2A (p.Val2Ala), gnomAD X-114726941-T-C, REVEL 0.17, MetaLR 0.09
- V2V (p.Val2Val), rs990221992, gnomAD X-114726942-G-A, CADD 9.07
- N3K (p.Asn3Lys), cosmic curated COSV52202, REVEL 0.07, MetaLR 0.09
- N3S (p.Asn3Ser), rs142701803, ClinGen CA10495347, ClinVar RCV003937114, ESP rs142701803, REVEL 0.04, MetaLR 0.07, Uncertain significance, HTR2C-related disorder
- N3H (p.Asn3His), gnomAD X-114726943-A-C, REVEL 0.12, MetaLR 0.16
- N3N (p.Asn3Asn), gnomAD X-114726945-C-T, CADD 7.74
- L4V (p.Leu4Val), Ensembl rs2228669, MetaLR 0.10, MetaSVM -1.00
- L4M (p.Leu4Met), gnomAD X-114726946-C-A, REVEL 0.15, MetaLR 0.09
- L4R (p.Leu4Arg), gnomAD X-114726947-T-G, REVEL 0.24, MetaLR 0.18
- L4P (p.Leu4Pro), gnomAD X-114726947-T-C, REVEL 0.26, MetaLR 0.21
- L4L (p.Leu4Leu), gnomAD X-114726948-G-A, CADD 5.95
- R5S (p.Arg5Ser), cosmic curated COSV52206, REVEL 0.03, MetaLR 0.08
- R5G (p.Arg5Gly), gnomAD X-114726949-A-G, REVEL 0.07, MetaLR 0.06
- R5M (p.Arg5Met), gnomAD X-114726950-G-T, REVEL 0.06, MetaLR 0.08
- R5K (p.Arg5Lys), gnomAD X-114726950-G-A, REVEL 0.05, MetaLR 0.06
- R5R (p.Arg5Arg), rs2069486138, gnomAD X-114726951-G-A, CADD 8.77
- N6K (p.Asn6Lys), TOPMed rs2069486244, MetaLR 0.05, MetaSVM -1.05
- N6S (p.Asn6Ser), Ensembl rs967332066, REVEL 0.05, MetaLR 0.07
- N6D (p.Asn6Asp), gnomAD X-114726952-A-G, REVEL 0.03, MetaLR 0.07
- N6Y (p.Asn6Tyr), gnomAD X-114726952-A-T, REVEL 0.04, MetaLR 0.08
- A7E (p.Ala7Glu), 1000Genomes rs201115463, ExAC rs201115463, TOPMed rs201115463, gnomAD rs201115463, REVEL 0.03, MetaLR 0.08, Likely benign
- A7S (p.Ala7Ser), cosmic curated COSV10877, MetaLR 0.09, MetaSVM -1.03
- A7T (p.Ala7Thr), Ensembl rs79200422, REVEL 0.02, MetaLR 0.09
- A7V (p.Ala7Val), rs201115463, ClinGen CA10495348, NCI-TCGA Cosmic COSV5220, cosmic curated COSV52202, REVEL 0.09, MetaLR 0.07, Likely benign, not provided
- A7A (p.Ala7Ala), rs202034357, gnomAD X-114726957-G-A, CADD 7.12
- V8M (p.Val8Met), Ensembl rs2069486549, REVEL 0.18, MetaLR 0.18
- V8del (p.Val8del), rs2069486491, gnomAD X-114726956-CGGT-, CADD 16.10
- V8L (p.Val8Leu), gnomAD X-114726958-G-C, REVEL 0.10, MetaLR 0.10
- V8A (p.Val8Ala), gnomAD X-114726959-T-C, REVEL 0.23, MetaLR 0.10
- V8V (p.Val8Val), gnomAD X-114726960-G-C, CADD 5.62
- H9P (p.His9Pro), ExAC rs782138701, gnomAD rs782138701, MetaLR 0.07, MetaSVM -1.06
- H9R (p.His9Arg), ExAC rs782138701, gnomAD rs782138701, REVEL 0.10, MetaLR 0.05
- H9Y (p.His9Tyr), ExAC rs781962054, gnomAD rs781962054, REVEL 0.11, MetaLR 0.07
- H9N (p.His9Asn), gnomAD X-114726961-C-A, REVEL 0.09, MetaLR 0.07
- H9D (p.His9Asp), gnomAD X-114726961-C-G, REVEL 0.10, MetaLR 0.07
- H9L (p.His9Leu), gnomAD X-114726962-A-T, REVEL 0.05, MetaLR 0.06
- H9Q (p.His9Gln), gnomAD X-114726963-T-A, REVEL 0.06, MetaLR 0.05
- H9H (p.His9His), rs782762018, gnomAD X-114726963-T-C, CADD 0.37
- S10L (p.Ser10Leu), gnomAD rs1556422215, REVEL 0.13, MetaLR 0.08
- S10T (p.Ser10Thr), gnomAD X-114726964-T-A, REVEL 0.04, MetaLR 0.08
- S10P (p.Ser10Pro), gnomAD X-114726964-T-C, REVEL 0.11, MetaLR 0.10
- S10* (p.Ser10Ter), gnomAD X-114726965-C-A, CADD 34.00
- S10S (p.Ser10Ser), gnomAD X-114726966-A-T, CADD 0.31
- F11=, NCI-TCGA Cosmic COSV5222, Variant assessed as somatic; low impact.
- F11L (p.Phe11Leu), ExAC rs782136328, gnomAD rs782136328, REVEL 0.05, MetaLR 0.05
- F11I (p.Phe11Ile), gnomAD X-114726967-T-A, REVEL 0.03, MetaLR 0.08
- F11S (p.Phe11Ser), gnomAD X-114726968-T-C, REVEL 0.21, MetaLR 0.09
- F11F (p.Phe11Phe), gnomAD X-114726969-C-T, CADD 14.00
- L12F (p.Leu12Phe), ExAC rs199958275, gnomAD rs199958275, REVEL 0.04, MetaLR 0.13
- L12I (p.Leu12Ile), cosmic curated COSV52226, REVEL 0.03, MetaLR 0.09
- L12P (p.Leu12Pro), gnomAD X-114726966-A-AT, CADD 21.20
- L12H (p.Leu12His), gnomAD X-114726971-T-A, REVEL 0.33, MetaLR 0.17
- L12L (p.Leu12Leu), gnomAD X-114731294-T-G, CADD 9.29
- V13A (p.Val13Ala), ExAC rs781840760, gnomAD rs781840760, REVEL 0.11, MetaLR 0.11
- V13L (p.Val13Leu), gnomAD X-114731295-G-T, REVEL 0.05, MetaLR 0.07
- V13V (p.Val13Val), gnomAD X-114731297-G-A, CADD 8.82
- H14Q (p.His14Gln), gnomAD rs78203490, REVEL 0.18, MetaLR 0.16
- H14N (p.His14Asn), gnomAD X-114731298-C-A, REVEL 0.17, MetaLR 0.18
- H14Y (p.His14Tyr), gnomAD X-114731298-C-T, REVEL 0.18, MetaLR 0.19
- H14R (p.His14Arg), gnomAD X-114731299-A-G, REVEL 0.23, MetaLR 0.18
- L15I (p.Leu15Ile), gnomAD X-114731301-C-A, REVEL 0.11, MetaLR 0.18
- L15L (p.Leu15Leu), rs782483805, gnomAD X-114731301-C-T, CADD 9.26
- L15P (p.Leu15Pro), gnomAD X-114731302-T-C, REVEL 0.27, MetaLR 0.21
- I16T (p.Ile16Thr), ESP rs375844687, ExAC rs375844687, TOPMed rs375844687, gnomAD rs375844687, REVEL 0.28, MetaLR 0.07
- I16V (p.Ile16Val), gnomAD X-114731304-A-G, REVEL 0.08, MetaLR 0.07
- I16S (p.Ile16Ser), gnomAD X-114731305-T-G, REVEL 0.21, MetaLR 0.08
- I16I (p.Ile16Ile), gnomAD X-114731306-T-A, CADD 9.48
- G17V (p.Gly17Val), cosmic curated COSV52226, ExAC rs782253520, REVEL 0.32, MetaLR 0.26
- G17C (p.Gly17Cys), gnomAD X-114731307-G-T, REVEL 0.35, MetaLR 0.26
- G17A (p.Gly17Ala), gnomAD X-114731308-G-C, REVEL 0.23, MetaLR 0.22
- G17D (p.Gly17Asp), gnomAD X-114731308-G-A, REVEL 0.27, MetaLR 0.25
- G17G (p.Gly17Gly), rs201323909, gnomAD X-114731309-C-A, CADD 9.31
- L18I (p.Leu18Ile), cosmic curated COSV99348, REVEL 0.17, MetaLR 0.25
- L18V (p.Leu18Val), gnomAD rs1556423227, REVEL 0.18, MetaLR 0.22
- L18L (p.Leu18Leu), gnomAD X-114731310-C-T, CADD 9.11
- L18R (p.Leu18Arg), gnomAD X-114731311-T-G, REVEL 0.32, MetaLR 0.24
- L18P (p.Leu18Pro), gnomAD X-114731311-T-C, REVEL 0.32, MetaLR 0.24
- L19F (p.Leu19Phe), NCI-TCGA TCGA novel, REVEL 0.14, MetaLR 0.20, Variant assessed as somatic; moderate impact.
- L19S (p.Leu19Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L19W (p.Leu19Trp), Ensembl rs2069533983
- V20F (p.Val20Phe), gnomAD X-114731316-G-T, REVEL 0.19, MetaLR 0.11
- W21C (p.Trp21Cys), gnomAD X-114731319-TG-T, CADD 27.70
- W21L (p.Trp21Leu), gnomAD X-114731320-G-T, REVEL 0.24, MetaLR 0.23
- Q22K (p.Gln22Lys), rs1556423232, NCI-TCGA Cosmic COSV5222, cosmic curated COSV52221, TOPMed rs1556423232, REVEL 0.12, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- S23=, rs6318, ClinVar RCV000010563, ClinVar RCV000835770, ClinVar RCV003974817, Benign
- S23C (p.Ser23Cys), rs6318, UniProt VAR 003450, 1000Genomes rs6318, ESP rs6318, CADD 5.88, PolyPhen-2 0.00, Benign
- S23F (p.Ser23Phe), 1000Genomes rs6318, ESP rs6318, ExAC rs6318, TOPMed rs6318, CADD 4.07, PolyPhen-2 0.00, Benign
- S23P (p.Ser23Pro), gnomAD X-114731325-T-C, REVEL 0.12, CADD 18.20
- D24G (p.Asp24Gly), NCI-TCGA TCGA novel, REVEL 0.17, MetaLR 0.10, Variant assessed as somatic; moderate impact.
- D24N (p.Asp24Asn), cosmic curated COSV52213, REVEL 0.07, MetaLR 0.06
- D24Y (p.Asp24Tyr), gnomAD X-114731328-G-T, REVEL 0.24, MetaLR 0.12
- I25V (p.Ile25Val), ESP rs137903956, ExAC rs137903956, gnomAD rs137903956, REVEL 0.03, MetaLR 0.06
- I25F (p.Ile25Phe), gnomAD X-114731331-A-T, REVEL 0.04, MetaLR 0.07
- I25I (p.Ile25Ile), gnomAD X-114731333-T-C, CADD 6.99
- S26F (p.Ser26Phe), cosmic curated COSV10637, REVEL 0.12, MetaLR 0.15
- S26Y (p.Ser26Tyr), cosmic curated COSV52216, REVEL 0.12, MetaLR 0.15
- V27L (p.Val27Leu), NCI-TCGA Cosmic COSV9934, cosmic curated COSV99349, REVEL 0.03, MetaLR 0.07, Variant assessed as somatic; moderate impact.
- V27* (p.Val27Ter), gnomAD X-114731335-CT-C, CADD 23.20
- V27G (p.Val27Gly), gnomAD X-114731338-T-G, REVEL 0.15, MetaLR 0.21
- S28N (p.Ser28Asn), gnomAD rs201731034, REVEL 0.03, MetaLR 0.09
- S28S (p.Ser28Ser), rs1240494579, gnomAD X-114731342-C-T, CADD 6.63
- S28R (p.Ser28Arg), gnomAD X-114731342-C-A, REVEL 0.18, MetaLR 0.15
- P29R (p.Pro29Arg), gnomAD rs1556423251, REVEL 0.24, MetaLR 0.16
- P29T (p.Pro29Thr), NCI-TCGA Cosmic COSV9935, cosmic curated COSV99351, REVEL 0.18, MetaLR 0.17, Variant assessed as somatic; moderate impact.
- P29Q (p.Pro29Gln), gnomAD X-114731341-GC-G, CADD 23.00
- P29L (p.Pro29Leu), gnomAD X-114731344-C-T, REVEL 0.19, MetaLR 0.11
- P29P (p.Pro29Pro), gnomAD X-114731345-A-C, CADD 7.91
- V30A (p.Val30Ala), ESP rs369056461, ExAC rs369056461, TOPMed rs369056461, gnomAD rs369056461, REVEL 0.17, MetaLR 0.14
- V30V (p.Val30Val), rs782300498, gnomAD X-114731348-A-G, CADD 5.93
- A31T (p.Ala31Thr), ExAC rs781966894, gnomAD rs781966894, MetaLR 0.07, MetaSVM -1.06
- A31V (p.Ala31Val), rs201249233, ClinGen CA10495394, ClinVar RCV003412229, ClinVar RCV004927909, REVEL 0.06, MetaLR 0.07, Uncertain significance, not specified
- A32D (p.Ala32Asp), NCI-TCGA Cosmic COSV5221, NCI-TCGA Cosmic COSV9934, cosmic curated COSV99348, Variant assessed as somatic; moderate impact.
- A32G (p.Ala32Gly), NCI-TCGA Cosmic COSV5221, cosmic curated COSV52215, NCI-TCGA Cosmic COSV9934, Variant assessed as somatic; moderate impact.
- A32T (p.Ala32Thr), cosmic curated COSV10500, TOPMed rs1278561742
- A32V (p.Ala32Val), cosmic curated COSV10959, MetaLR 0.07, MetaSVM -1.05
- A32A (p.Ala32Ala), rs782388278, gnomAD X-114731354-T-A, CADD 7.51
- I33K (p.Ile33Lys), cosmic curated COSV52220, MetaLR 0.08, MetaSVM -1.04
- I33M (p.Ile33Met), ExAC rs199898127, TOPMed rs199898127, gnomAD rs199898127, REVEL 0.08, MetaLR 0.08, Uncertain significance, HTR2C-related disorder
- I33R (p.Ile33Arg), 1000Genomes rs782499464, ExAC rs782499464, TOPMed rs782499464, gnomAD rs782499464, REVEL 0.11, MetaLR 0.08
- I33T (p.Ile33Thr), 1000Genomes rs782499464, ExAC rs782499464, TOPMed rs782499464, gnomAD rs782499464, REVEL 0.07, MetaLR 0.08, Uncertain significance, not specified
- V34I (p.Val34Ile), TOPMed rs2069535008, MetaLR 0.10, MetaSVM -1.03
- D36E (p.Asp36Glu), TOPMed rs2069535051, MetaLR 0.13, MetaSVM -1.00, Uncertain significance, HTR2C-related disorder
- I37V (p.Ile37Val), cosmic curated COSV52215, MetaLR 0.07, MetaSVM -1.03
- F38Y (p.Phe38Tyr), Ensembl rs2069535095, MetaLR 0.07, MetaSVM -0.97
- F38L (p.Phe38Leu), gnomAD X-114731372-C-A, REVEL 0.18, MetaLR 0.04
- T40A (p.Thr40Ala), cosmic curated COSV52222, gnomAD rs2069535158, REVEL 0.09, MetaLR 0.04, Uncertain significance, HTR2C-related disorder
- T40N (p.Thr40Asn), gnomAD X-114731377-C-A, REVEL 0.05, MetaLR 0.09
- S41S (p.Ser41Ser), rs868907406, gnomAD X-114731381-C-T, CADD 10.20
- D42H (p.Asp42His), rs143566182, ClinGen CA10495398, ClinVar RCV000914492, ClinVar RCV003913049, REVEL 0.20, MetaLR 0.13, Likely benign, not provided
- D42N (p.Asp42Asn), cosmic curated COSV52202, REVEL 0.11, MetaLR 0.08, Uncertain significance, HTR2C-related disorder
- D42Y (p.Asp42Tyr), cosmic curated COSV52203, MetaLR 0.14, MetaSVM -0.92
- G43A (p.Gly43Ala), NCI-TCGA Cosmic COSV9934, cosmic curated COSV99347, Variant assessed as somatic; moderate impact.
- G43C (p.Gly43Cys), cosmic curated COSV52204, ExAC rs781924099, gnomAD rs781924099, REVEL 0.19, MetaLR 0.14
- G43D (p.Gly43Asp), Ensembl rs79798811, MetaLR 0.08, MetaSVM -1.06
- G44E (p.Gly44Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G44V (p.Gly44Val), NCI-TCGA TCGA novel, MetaLR 0.17, MetaSVM -0.89, Variant assessed as somatic; moderate impact.
- G44G (p.Gly44Gly), rs1556423296, gnomAD X-114731390-A-C, CADD 11.90
- R45C (p.Arg45Cys), rs1556423301, NCI-TCGA Cosmic COSV5220, NCI-TCGA Cosmic COSV5221, cosmic curated COSV52219, REVEL 0.19, MetaLR 0.20, Variant assessed as somatic; moderate impact.
- R45H (p.Arg45His), cosmic curated COSV10437, gnomAD rs1556423306, REVEL 0.17, MetaLR 0.14
- R45S (p.Arg45Ser), cosmic curated COSV52200, REVEL 0.17, MetaLR 0.11
- F46S (p.Phe46Ser), ExAC rs782099601, gnomAD rs782099601, REVEL 0.26, MetaLR 0.07
- K47E (p.Lys47Glu), ExAC rs782725427, gnomAD rs782725427, REVEL 0.13, MetaLR 0.05
- K47R (p.Lys47Arg), gnomAD rs1556423310, REVEL 0.03, MetaLR 0.05
- F48I (p.Phe48Ile), cosmic curated COSV52202, MetaLR 0.07, MetaSVM -1.07
- D50E (p.Asp50Glu), NCI-TCGA TCGA novel, MetaLR 0.04, MetaSVM -1.00, Variant assessed as somatic; moderate impact.
- D50D (p.Asp50Asp), rs202042319, gnomAD X-114731408-C-T, CADD 8.51
- G51E (p.Gly51Glu), cosmic curated COSV52211, MetaLR 0.03, MetaSVM -1.04
- G51R (p.Gly51Arg), cosmic curated COSV10959, NCI-TCGA TCGA novel, REVEL 0.20, MetaLR 0.03, Variant assessed as somatic; moderate impact.
- G51G (p.Gly51Gly), gnomAD X-114731411-G-T, CADD 9.47
- V52I (p.Val52Ile), ExAC rs74465306, TOPMed rs74465306, gnomAD rs74465306, REVEL 0.08, MetaLR 0.04
- V52L (p.Val52Leu), ExAC rs74465306, TOPMed rs74465306, gnomAD rs74465306, REVEL 0.17, MetaLR 0.03
- V52V (p.Val52Val), rs782816996, gnomAD X-114731414-A-G, CADD 9.96
- Q53E (p.Gln53Glu), 1000Genomes rs2147346353, MetaLR 0.06, MetaSVM -1.05
- N54I (p.Asn54Ile), cosmic curated COSV52210, MetaLR 0.08, MetaSVM -1.10
- W55C (p.Trp55Cys), gnomAD rs1556423325, REVEL 0.47, MetaLR 0.15
- W55G (p.Trp55Gly), NCI-TCGA Cosmic COSV5220, NCI-TCGA Cosmic COSV5221, cosmic curated COSV52218, NCI-TCGA Cosmic COSV9935, Variant assessed as somatic; moderate impact.
- W55R (p.Trp55Arg), Ensembl rs1304127953, NCI-TCGA Cosmic COSV5220, cosmic curated COSV52201, NCI-TCGA Cosmic COSV5221, MetaLR 0.14, MetaSVM -0.99, Variant assessed as somatic; moderate impact.
- P56S (p.Pro56Ser), NCI-TCGA Cosmic COSV5220, cosmic curated COSV52203, MetaLR 0.08, MetaSVM -1.11, Variant assessed as somatic; moderate impact.
- A57E (p.Ala57Glu), cosmic curated COSV52211
- A57P (p.Ala57Pro), Ensembl rs74959059, MetaLR 0.15, MetaSVM -0.88
- L58F (p.Leu58Phe), rs1448152418, ClinGen CA414318082, ClinVar RCV003420880, TOPMed rs1448152418, REVEL 0.22, MetaLR 0.15, Uncertain significance, HTR2C-related disorder
- S59P (p.Ser59Pro), ExAC rs781896215, TOPMed rs781896215, gnomAD rs781896215, REVEL 0.18, MetaLR 0.07
- S59T (p.Ser59Thr), ExAC rs781896215, TOPMed rs781896215, gnomAD rs781896215, REVEL 0.06, MetaLR 0.05
- I60M (p.Ile60Met), NCI-TCGA Cosmic COSV5222, NCI-TCGA Cosmic COSV9934, MetaLR 0.08, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- I60V (p.Ile60Val), rs1173878618, ClinGen CA414318091, ClinVar RCV003904644, TOPMed rs1173878618, REVEL 0.19, MetaLR 0.09, Uncertain significance, HTR2C-related disorder
- I60I (p.Ile60Ile), rs200005746, gnomAD X-114731438-C-T, CADD 1.86
- V61F (p.Val61Phe), cosmic curated COSV52210, MetaLR 0.04, MetaSVM -1.02
- V61I (p.Val61Ile), rs371347099, ClinGen CA10495407, NCI-TCGA Cosmic COSV5221, NCI-TCGA Cosmic COSV9934, REVEL 0.01, MetaLR 0.03, Uncertain significance, HTR2C-related disorder
- I62T (p.Ile62Thr), ExAC rs782220418, gnomAD rs782220418, REVEL 0.14, MetaLR 0.06
- I62I (p.Ile62Ile), gnomAD X-114731444-C-A, CADD 1.09
- I63M (p.Ile63Met), cosmic curated COSV52210, MetaLR 0.11, MetaSVM -0.99
- I63V (p.Ile63Val), ExAC rs782475474, gnomAD rs782475474, REVEL 0.07, MetaLR 0.05
- I64T (p.Ile64Thr), NCI-TCGA Cosmic COSV9934, cosmic curated COSV99349, MetaLR 0.13, MetaSVM -0.98, Variant assessed as somatic; moderate impact.
- I65L (p.Ile65Leu), NCI-TCGA Cosmic COSV5220, cosmic curated COSV52209, MetaLR 0.03, MetaSVM -0.98, Variant assessed as somatic; moderate impact.
- I65V (p.Ile65Val), gnomAD X-114731451-A-G, REVEL 0.09, MetaLR 0.05
- I65T (p.Ile65Thr), gnomAD X-114731452-T-C, REVEL 0.15, MetaLR 0.11
- M66I (p.Met66Ile), cosmic curated COSV10805, cosmic curated COSV52228
Public HTR2C analysis runs
- HTR2C analysis run — HTR2C (745 variants) — completed 2026-08-19